Cargando…
Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses
More than many other fields in medicine, cancer vaccine development has been plagued by a wide gap between the massive amounts of highly encouraging preclinical data on one hand, and the disappointing clinical results on the other. It is clear now that traditional approaches from the infectious dise...
Autor principal: | Vermaelen, Karim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349827/ https://www.ncbi.nlm.nih.gov/pubmed/30723469 http://dx.doi.org/10.3389/fimmu.2019.00008 |
Ejemplares similares
-
Long Lasting Cellular Immune Response Induced by mRNA Vaccination: Implication for Prevention Strategies
por: Vitiello, Laura, et al.
Publicado: (2022) -
Measurement of Cellular Immune Response to Viral Infection and Vaccination
por: Bouwman, Wilbert, et al.
Publicado: (2020) -
Characterization of the early cellular immune response induced by HPV vaccines
por: Pasmans, Hella, et al.
Publicado: (2022) -
Editorial: Dendritic cell-primed T cells in anti-tumor immune responses and relevant vaccine strategies
por: Leavenworth, Jianmei W., et al.
Publicado: (2022) -
Dendritic Cell-Based Immunotherapy in Lung Cancer
por: Stevens, Dieter, et al.
Publicado: (2021)